Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CNSI Cambridge Neuroscience -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (565)	4/14/2000 2:31:00 AM
From: scott_jiminez	Read Replies (1) \| Respond to of 675

Mike - thanks for waking me up to CNSI again. Tell ya what, I'll go off line and do some homework and check back in a little while. You might want to do a pubmed search for Martin Raff (Raff MC) who did some pioneering work on the mechanisms underlying glial (oligodendrocytes are one type of glial cell) differentiation in the optic nerve. While my knowledge of this work is quite dated, I recall he was instrumental in working out the temporal sequence of growth factors necessary to produce an oligo. I'm sure his work laid part of the foundation for understanding the putative role of growth factors in initiating remyelination. Martin Schwab (Schwab ME) is another name worth pursuing. And a personal opinion: I would feel comfortable in assuming there are stockholders in literally thousands of companies who have posted messages over the past couple of weeks to the effect, Would anyone like to tell me why this #@%& stock has fallen 50%? I knew I shouldn't have trusted ___________ (fill in name of CEO or CFO or Greenspan or Abby Cohen, etc.)'* The fact is that hundreds, if not thousands, of stocks have done EXACTLY what CNSI has done...all for no 'apparent' reason. VERY few stocks are immune to large-scale market forces and this applies to companies with stellar earnings and to those with no earnings for the foreseeable future. In fact, CNSI's ~50% correction from its rally high is actually quite modest - as I'm sure you're well aware - within the biotech universe (ex. see the March performance of the Genomics/bioinformatics index here siliconinvestor.com